Skip to main content
A-LevelBiologyGenetic technology9700/41 · May/June 2023 · Q411 Marks

Recombinant human proteins can be used to treat disease.

  1. (a)(i)Define the term recombinant DNA.[1]
  2. (a)(ii)From the 1920s until the 1970s, insulin obtained from the bodies of animals was used to treat diabetes. From the 1970s, recombinant human insulin was used instead. Explain the advantages of using recombinant human insulin to treat people with diabetes.[3]
  3. (b)(i)Insulin is composed of two polypeptide chains, the A chain and the B chain, that are linked by disulfide bonds. Variations in amino acid sequence occur: • in the insulin molecules of different animals • in new versions of human insulin that have been engineered to control blood glucose concentration more effectively than normal recombinant human insulin. These new versions of human insulin are called analogues. Table 4.1 shows the amino acid positions where variation occurs in different animal and human analogue insulin molecules. The dashes indicate a missing amino acid. Cats with diabetes can be successfully treated with insulin injections. Cat insulin is not available, but vets can choose from the other types of insulin shown in Table 4.1. Identify the type of insulin that is most suitable for treating cats.[1]
  4. (b)(ii)Suggest ways in which analogue insulin molecules can be produced by genetic engineering techniques.[3]
  5. (c)Information about amino acid and nucleotide sequences is stored in computer databases. Outline the advantages of using databases of nucleotide sequences to investigate evolutionary relationships between species.[3]

Mark scheme

Marking points from the official mark scheme (May/June 2023). The mark or mark type is shown in brackets.

  1. DNA, combined / joined, from, two / different, organisms / sources ;
  2. (protein made in, bacteria/yeast, so) 1 can be made in, large / unlimited, quantities ;
  3. 2 cheap to make / low cost / cost-efficient ;
  4. 3 does not, harm / involve, animals / pigs / cows ;
  5. 4 no risk of (named) disease, transfer / infection ;
  6. (sequence identical to human sequence so) 5 does not cause, allergy / inflammatory response / immune response / antibody production ;
  7. 6 acts more rapidly ;
  8. 7 do not, develop tolerance to it / need larger doses ;
  9. cow;
  10. 1 obtain (normal human), gene / DNA, from (m)RNA by reverse transcriptase / using restriction enzyme ;
  11. 2 use gene editing (to alter human gene);
  12. 3 obtain (nucleotide) sequence for (normal human) insulin gene;
  13. 4 synthesise, new / analogue, gene / nucleotide sequence ;
  14. 5 put, new / analogue, gene in, bacteria / yeast ;
  15. 6 add promoter for, gene expression / protein synthesis ;
  16. 7 AVP;
  17. 1 can, share / search / access, data(base) / information / sequences ;
  18. 2 from anywhere / online ;
  19. 3 can, compare / align / analyse, (multiple) sequences ;
  20. 4 rapid / fast(er) (process) ;
  21. 5 can, quantify / count, nucleotide differences ;
  22. 6 closely-related species have few, differences / mutations ;

Write your answer and get it marked

On Oracle Prep you can write or photograph your own answer and have it marked by AI against this mark scheme, with feedback on what you missed.

Sign up free →

About this question

Topic
Genetic technology, A-Level Biology (syllabus 9700). Structured question, 11 marks.
Source
A-Level Biology, May/June 2023 Paper 4 Variant 1, question 4.

Questions and mark schemes are from past examination papers and remain the copyright of the exam board. How Oracle Prep builds its content

Related Biology questions

© 2026 Oracle Prep